Revvity, Inc. (RVTY)
NYSE · Health Care · market cap 11.66B
Share price
$151.70
At the last nightly close
Intrinsic value
$88.42
Range $88.42 – $94.76 — the conservative figure is the low end.
Margin of safety
-41.7%
($88.42 − $151.70) ÷ $151.70
EV / EBIT
n/a
Not ranked: short history.
How these numbers are computed
The valuations are calculated in Python from filed accounts, not written by a language model. Three methods run side by side: earnings power value, which capitalises a normalised operating profit; a free-cash-flow model; and the Graham Number as an asset-side cross-check. The conservative figure above starts from the lower of the first two; the Graham Number never enters it.
The frame gives no credit for growth unless the company has earned it: only a return on invested capital that has beaten the cost of capital year after year earns a growth credit, and that credit is capped. A company that compounds will therefore usually read as expensive against it — that is deliberate. It is a price-discipline floor, not a price target, and it is not a view on what the shares will do.
The EV/EBIT ranking uses the median operating profit of up to fifteen fiscal years — a full cycle — where the free screeners use the last twelve months. When the data cannot support a method, the figure reads n/a rather than a number: a free-cash-flow valuation on a bank, a PEG on erratic earnings, a multiple on a company with no operating profit to speak of.
Fundamentals from SEC EDGAR. Prices, market data and technicals from yfinance. Valuation computed 2026-08-29.
Key metrics
Market position
Annual financials
| Period | Revenue | Operating income | Net income | EPS | Free cash flow |
|---|---|---|---|---|---|
| 2025-FY | 2.86B | 356.6M | 241.2M | 2.15 | 509.4M |
| 2024-FY | 2.76B | 346.7M | 270.4M | 2.24 | 541.7M |
| 2023-FY | 2.75B | 300.6M | 693.1M | 5.62 | 9.9M |
| 2022-FY | 3.31B | 742.7M | 569.2M | 8.12 | 594.2M |
| 2021-FY | 3.78B | 867.3M | 727.9M | 6.49 | 828.5M |
Filed figures from SEC EDGAR, in the reporting currency.
Next earnings
Recent news
- Revvity (RVTY) slides as investors weigh softer growth profile and fresh analyst caution ahead of upcoming events | Quiver Quantitativequiverquant.com
- RVTY Q1 2026 Deep Dive: Portfolio Pruning and AI Investments Shape Outlook - StockStorystockstory.org
- Revvity (RVTY) Earnings Date and Reports 2026marketbeat.com
- Revvity (RVTY) Q2 Earnings and Revenues Surpass Estimatesfinance.yahoo.com
- Revvity, Inc. (RVTY) Stock Price, News, Quote & History - Yahoo Financefinance.yahoo.com
Headlines link to their source. Sperio does not republish article text.
The figures above are the arithmetic. To see what a board of eight AI agents makes of them — macro, sector, filings, news and a devil's advocate whose only job is to attack the thesis — run the full analysis on RVTY.
Run the board on RVTY10 free analyses · no signup, no card
This page presents computed figures and filed financial data for information only. It is not investment advice, not a recommendation to buy or sell any security, and not a statement about what these shares will do. Sperio is a research tool, not an investment adviser. Figures are derived automatically from public filings and market data and may be incomplete, out of date or wrong. See the Terms & Disclaimer.